The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aclaris Therapeutics, Inc. | COM | 00461U105 | 13,946 | 794,171 | SH | SOLE | 791,171 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 6,151 | 883,720 | SH | SOLE | 883,720 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 3,518 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Allakos Inc | COM | 01671P100 | 12,486 | 146,259 | SH | SOLE | 146,259 | 0 | 0 | ||
Allakos Inc | COM | 01671P100 | 7,086 | 83,000 | SH | Call | SOLE | 83,000 | 0 | 0 | |
Allovir, Inc | COM | 019818103 | 1,625 | 82,336 | SH | SOLE | 82,336 | 0 | 0 | ||
Alpine Immune Sciences Inc | COM | 02083G100 | 2,477 | 275,169 | SH | SOLE | 275,169 | 0 | 0 | ||
Amarin Corp PLC | SPONS ADR NEW | 023111206 | 110 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
Atreca Inc | COM | 04965G109 | 3,381 | 396,835 | SH | SOLE | 396,835 | 0 | 0 | ||
Avadel Pharmaceuticals PLC | SPONS ADR | 05337M104 | 3,696 | 549,250 | SH | SOLE | 549,250 | 0 | 0 | ||
BCLS Acquisition Corp | COM | G0904B105 | 3,159 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
BCTG Acquisition Corp | COM | 05492W103 | 5,690 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
BioNTech SE | SPONS ADS | 09075V102 | 1,289 | 5,758 | SH | SOLE | 5,758 | 0 | 0 | ||
Bolt Biotherapeutics, Inc | COM | 097702104 | 11,401 | 737,459 | SH | SOLE | 737,459 | 0 | 0 | ||
Catabasis Pharmaceuticals Inc | COM | 14875P206 | 317 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
Centessa Pharmaceuticals PLC | SPONS ADS | 152309100 | 34,149 | 1,537,533 | SH | SOLE | 1,537,533 | 0 | 0 | ||
Chinook Therapeutics Inc | COM | 16961L106 | 44,738 | 3,168,388 | SH | SOLE | 3,168,388 | 0 | 0 | ||
Consonance HFW Acquisition Co | COM | G2445M129 | 3,120 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
Day One Biopharmaceuticals | COM | 23954D109 | 4,611 | 202,500 | SH | SOLE | 202,500 | 0 | 0 | ||
Decibel Therapeutics Inc | COM | 24343R106 | 7,107 | 826,422 | SH | SOLE | 826,422 | 0 | 0 | ||
Equillium, Inc. | COM | 29446K106 | 4,348 | 738,176 | SH | SOLE | 738,176 | 0 | 0 | ||
Elevation Oncology Inc | COM | 28623U101 | 12,650 | 932,239 | SH | SOLE | 932,239 | 0 | 0 | ||
Eyepoint Pharmaceuticals Inc | COM | 30233G209 | 4,046 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
Forma Therapeutics Holdings, Inc. | COM | 34633R104 | 38,966 | 1,565,529 | SH | SOLE | 1,565,529 | 0 | 0 | ||
Graphite Bio Inc | COM | 38870X104 | 228,374 | 7,431,623 | SH | SOLE | 7,431,623 | 0 | 0 | ||
Immunocore Holdings Limited | SPONS ADS | 45258D105 | 2,499 | 64,000 | SH | SOLE | 64,000 | 0 | 0 | ||
Instil Bio Inc | COM | 45783C101 | 41,449 | 2,145,395 | SH | SOLE | 2,145,395 | 0 | 0 | ||
Intercept Pharmaceuticals Inc | COM | 45845P108 | 12,795 | 640,688 | SH | SOLE | 640,688 | 0 | 0 | ||
Iveric Bio, Inc. | COM | 46583P102 | 13,411 | 2,125,371 | SH | SOLE | 2,125,371 | 0 | 0 | ||
Janux Therapeutics Inc. | COM | 47103J105 | 15,168 | 607,949 | SH | SOLE | 607,949 | 0 | 0 | ||
Jiya Acquisition Corp | COM | 47760M102 | 5,040 | 507,041 | SH | SOLE | 507,041 | 0 | 0 | ||
Kala Pharmaceuticals Inc | COM | 483119103 | 3,186 | 601,162 | SH | SOLE | 601,162 | 0 | 0 | ||
Kronos Bio Inc | COM | 50107A104 | 1,871 | 78,131 | SH | SOLE | 78,131 | 0 | 0 | ||
Lifesci Acquisition II Corp | COM | 53229E103 | 2,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 359 | 18,225 | SH | SOLE | 18,225 | 0 | 0 | ||
Nkarta, Inc. | COM | 65487U108 | 64,480 | 2,034,703 | SH | SOLE | 2,034,703 | 0 | 0 | ||
Novavax, Inc. | COM | 670002401 | 6,403 | 30,160 | SH | SOLE | 30,160 | 0 | 0 | ||
Novavax, Inc. | COM | 670002401 | 42,165 | 198,600 | SH | Call | SOLE | 198,600 | 0 | 0 | |
Odonate Therapeutics Inc | COM | 676079106 | 2,444 | 700,421 | SH | SOLE | 700,421 | 0 | 0 | ||
Rain Therapeutics Inc | COM | 75082Q105 | 25,444 | 1,637,308 | SH | SOLE | 1,637,308 | 0 | 0 | ||
Recursion Pharmaceuticals Inc | COM | 75629V104 | 28,309 | 775,583 | SH | SOLE | 775,583 | 0 | 0 | ||
Rhythm Pharmaceuticals Inc | COM | 76243J105 | 5,880 | 300,293 | SH | SOLE | 300,293 | 0 | 0 | ||
Rocket Pharmaceuticals Inc | COM | 77313F106 | 1,796 | 40,550 | SH | SOLE | 40,550 | 0 | 0 | ||
Springworks Therapeutics Inc | COM | 85205L107 | 13,998 | 169,852 | SH | SOLE | 169,852 | 0 | 0 | ||
Sutro BioPharma Inc | COM | 869367102 | 31,149 | 1,675,579 | SH | SOLE | 1,675,579 | 0 | 0 | ||
Syros Pharmaceuticals Inc | COM | 87184Q107 | 10,599 | 2,189,199 | SH | SOLE | 2,189,199 | 0 | 0 | ||
Terns Pharmaceuticals, Inc | COM | 880881107 | 3,544 | 289,068 | SH | SOLE | 289,068 | 0 | 0 | ||
Viracta Therapeutics Inc | COM | 92765F108 | 8,063 | 711,039 | SH | SOLE | 711,039 | 0 | 0 | ||
Vistagen Therapeutics Inc | COM | 92840H202 | 2,308 | 732,596 | SH | SOLE | 732,596 | 0 | 0 | ||
Verona Pharma PLC. | SPONS ADS | 925050106 | 7,267 | 1,111,112 | SH | SOLE | 1,111,112 | 0 | 0 |